Protalix BioTherapeutics, Inc. (PLX)

Last Closing Price: 3.02 (2026-11-18)

End Cash (Quarterly)

End Cash: The amount of cash held by the company for the given period.

Protalix BioTherapeutics, Inc. (PLX) had End Cash of $22.04M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$21.93M
$3.96M
$7.88M
$14.05M
$17.88M
$4.05M
$0.57M
$4.62M
$4.62M
$3.96M
$3.96M
$3.96M
$3.96M
$4.05M
$4.47M
80.46M
83.59M
$0.05
$0.05
Balance Sheet Financials
$98.87M
$5.77M
$19.37M
$118.24M
$30.23M
--
$7.46M
$37.69M
$80.55M
$80.55M
$80.55M
82.49M
Cash Flow Statement Financials
$15.53M
$-13.22M
$4.73M
$14.68M
End Cash
$22.04M
$7.36M
$1.53M
--
--
Fundamental Metrics & Ratios
3.27
--
--
--
--
64.08%
18.46%
18.46%
--
21.08%
18.07%
$13.44M
--
--
--
0.19
0.23
1.58
57.11
4.92%
4.92%
3.35%
4.92%
$0.98
$0.16
$0.19